A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R21AI137932-01A1
Leveraging immunostimulatory pathways that enhance BCG vaccination for the rational design of synthetic neonatal vaccine formulations
Molecular Mechanisms of Combination Adjuvants
Grant: 1U01AI124284-01
Dissecting the mechanism of age-specific adjuvant synergy in vitro and in vivo
Adjuvant Discovery
Grant: HHSN272201400052C
Adjuvant Discovery
Grant: 75N93019C00044
Development
Grant: HHSN272201800047C
Program Contracts, Development of Vaccines
Grant: 75N93020C00038
Human Immunology Project Consortium
Grant: U19AI118608-01A1
National Institutes of Health
Grant: 3U19AI118608-04S2
IMmunoPhenotyping Assessment of a Covid-19 Cohort (IMPACC): Clinical Site
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals